The Mispriced Trust Economy

What ‘Wealthy and Well Known’ Reveals About the Fracture Between Signal and Substance

Author: Shashank Heda, MD

Location: Dallas, Texas

Who Should Read This

• Professionals—physicians, consultants, engineers, scholars, entrepreneurs—who have spent years building genuine expertise and quietly wonder why louder, thinner voices seem to capture the contracts, the platforms, and the public influence they themselves have earned through substance
• Founders and enterprise builders who sense that the rules converting value into wealth have shifted beneath them, and who need a structural diagnosis of what changed—not a motivational sermon
• Readers and thinkers interested in the economics of attention, trust, and perception: anyone who has watched competence lose to confidence in a meeting, a market, or a public square and felt the distortion but lacked the vocabulary to name it
• Students of applied economics and institutional design who want to understand why the attention economy is not merely a cultural phenomenon but a structural misalignment with measurable consequences—and what guardrails might actually hold

Why Read This

• Because the most uncomfortable assertion in modern economics is not about inequality of wealth—it is about inequality of visibility. The market no longer rewards the most competent. It rewards the most believed. This article dissects that fracture.
• Because understanding why substance without signal is now economically fragile is not optional for anyone building a career, a venture, or an institution that depends on trust. The distortion is systemic, not anecdotal.
• Because the guardrails proposed here are not idealistic appeals to fairness. They are structural mechanisms—designed to financially bind attention to truth. That distinction matters.

I almost did not write this. The title alone—Wealthy and Well Known—carries a fragrance I instinctively avoid. Wealth adjacent to celebrity makes me uneasy. I have watched colleagues in Dallas, at UTSW, in consulting boardrooms, build reputations the old way: diagnostic precision, published results, operational turnarounds that saved departments from collapse. None of them were famous. Most were barely known outside their corridor.

Then I read the book. And the discomfort shifted.

The author’s most uncomfortable assertion—and I use that word deliberately, because it sat in my chest the way a difficult pathology slide sits before the diagnosis crystallizes—is this: the market does not reward the most competent people. It rewards the most visible and believed people. Competence matters, yes. But only after you are seen. Truth matters. But only after it is amplified. Expertise matters—only when wrapped in a story that travels. I wanted to reject this. I spent two decades in a discipline where the slide does not care about your brand. The cell is malignant or it is not. No amount of narrative changes the diagnosis.

But markets are not pathology slides. What the book diagnoses—and diagnosis is the right word here, not summary—is a structural fracture between two economic regimes. The old regime rewarded production, institutional affiliation, tangible capital. You built something, you owned something, you controlled something, and wealth followed. The new regime rewards perception, narrative velocity, audience capture. You are believed, you are repeated, you are amplified—and wealth follows. The shift is not moral. It is architectural. Platforms, algorithms, and reputation systems now mediate markets. Visibility is no longer an accessory to competence. It is the currency itself.

I confess I had not framed it this starkly before reading this. During CovidRxExchange—when we scaled from seven physicians on a cross-continental webinar to twenty thousand participants with zero pharmaceutical funding—I experienced this fracture without naming it. We had epistemic discipline. We had evidence-based protocols. We had clinical credibility but no signal infrastructure. The influencers with thinner clinical grounding but thicker social media presence captured more public trust in a month than we built in a year of rigorous work.

That was galling. But the book forces a harder question: was it also predictable?

Three Forces That Fractured the Old Alignment

I want to trace them as a diagnostician would—not as a commentator recycling the book’s structure, but through the lens of what I have seen break in real systems.

First, distribution decoupled from merit. Platforms reward what spreads, not what is true. The algorithm is agnostic to accuracy—it optimizes for engagement, for emotional velocity, for the dopamine architecture of the scroll.

Second, reputation became liquid. Authority can now be manufactured, purchased, inflated at scale. A physician with thirty years of clinical excellence and a LinkedIn influencer with a communications degree and a content team are, to the algorithm, equivalent signals.

Third—and this is where the distortion becomes dangerous—audiences cannot audit claims. Judgment is outsourced to proxies: follower counts, media appearances, institutional titles that may or may not reflect current capability.

The disease, then, is not a deficit of ethics. If I may propose a diagnostic frame: the disease is mispriced trust in an attention economy. And mispriced trust is not corrected by appeals to virtue. It is corrected by structural guardrails that bind incentives to outcomes.

Four Guardrails

The book proposes four guardrails, and I find them genuinely novel—not the anodyne prescriptions I expected.

The first: make outcomes louder than charisma. Track what people claimed against what actually happened. Over time, accuracy compounds. Charisma fades. In medicine, we have something analogous—morbidity and mortality conferences, where the case outcome audits the clinician’s judgment retrospectively. Imagine that discipline applied to public economic claims, policy predictions, market forecasts.

The second guardrail: treat reputation as capital—something that accrues interest through consistency and depletes through recklessness. Not reputation as costume. Reputation as ledger.

The third: make selling certainty costly. Today, reckless confidence carries negligible downside. The louder and more definitive the claim, the greater the responsibility should be. Honest error tolerated. Casual recklessness disciplined.

The fourth—and this one landed with particular force—build premium markets where entry is earned through track record, not branding. Markets where serious money and serious decisions concentrate around verified excellence rather than social gloss.

The Question the Book Does Not Answer

I keep returning to a question the book does not answer—and I respect it for not answering. Who builds these guardrails? The attention economy is not a policy failure waiting for a regulatory fix. It is an emergent property of platform architecture, human psychology, and capital incentive structures operating simultaneously. The entities with the power to redesign it—the platforms themselves—are the primary beneficiaries of the current distortion. That is not a coordination problem. That is a conflict of interest masquerading as a coordination problem.

In Sanatan Dharma, there is a concept—kartavya—that carries structural weight here. Duty that is not contingent on outcome. The physician diagnoses accurately whether or not the patient follows the treatment. The scholar publishes rigorous work whether or not the algorithm amplifies it. The entrepreneur builds sound architecture whether or not the market rewards signal over substance in this quarter. Kartavya does not solve the market distortion. But it inoculates the practitioner against the most pernicious sequelae of that distortion: the temptation to abandon substance for signal.

The attention economy is not retreating. Can we build structures that financially bind attention to truth before an entire generation of competent professionals concludes—rationally, not cynically—that substance is a losing strategy?

I do not know. But I know the cost of not trying. I have seen it on the faces of physicians who saved lives during a pandemic and watched influencers capture the credit. That is not a metaphor. That is a wound.

With obeisance to the Almighty and my Celestial Gurus. I request pardon for errors of judgment or expression. I invite your thoughts.

Author: Shashank Heda, MD

Location: Dallas, Texas

Raanan Group • February 2026